General Information of the Compound
| Compound ID |
CP0508347
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-2-morpholin-4-ylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H31N3O3
|
||||||||||||||||||
| Molecular Weight |
373.497
|
||||||||||||||||||
| Canonical SMILES |
O=C(CN1CCOCC1)Nc1cccc(OC2CCN(CC2)C2CCC2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H31N3O3/c25-21(16-23-11-13-26-14-12-23)22-17-3-1-6-20(15-17)27-19-7-9-24(10-8-19)18-4-2-5-18/h1,3,6,15,18-19H,2,4-5,7-14,16H2,(H,22,25)
Show/Hide
|
||||||||||||||||||
| InChIKey |
MAMYYKFGDRAMFJ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound